Russia Advances Personalized Cancer Fight with AI-Driven Vaccine Trials
Russia’s Gamaleya Institute unveils AI-assisted personalized cancer vaccine batches, pioneering mRNA-based immunotherapy tailored to patient genetics as part of a growing shift toward precision cancer treatment.